Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Quality of life (QL) is an important consideration when comparing adjuvant therapies for early breast cancer, especially if they differ substantially in toxicity. We evaluated QL and Q-TWiST among patients randomised to adjuvant dose-intensive epirubicin and cyclophosphamide administered with filgra...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2008
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359705/
https://ncbi.nlm.nih.gov/pubmed/18043579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604092
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items